Back to Search
Start Over
Loss-of-function mutations of bcor are an independent marker of adverse outcomes in intensively treated patients with acute myeloid leukemia
- Source :
- Cancers, Volume 13, Issue 9, Cancers, Vol 13, Iss 2095, p 2095 (2021), Cancers 13(9), 2095 (2021). doi:10.3390/cancers13092095
- Publication Year :
- 2021
-
Abstract
- Cancers 13(9), 2095 (2021). doi:10.3390/cancers13092095<br />Published by MDPI, Basel
Details
- Language :
- English
- Database :
- OpenAIRE
- Journal :
- Cancers, Volume 13, Issue 9, Cancers, Vol 13, Iss 2095, p 2095 (2021), Cancers 13(9), 2095 (2021). doi:10.3390/cancers13092095
- Accession number :
- edsair.doi.dedup.....572c76a2b1adb846c5674932da696401
- Full Text :
- https://doi.org/10.3390/cancers13092095